StocksMediumUpdated•Originally published 28 September 2026•Updated 28 September 2026•
1 min read
IDT Corp Beats Q4 Revenue Estimates but Misses on Adjusted EPS
Key Facts
1IDT Corporation reported an 18% increase in Q4 gross profit and a 52% surge in income from operations for fiscal year 2026.
2AngioDynamics announced it will report its fiscal 2027 first quarter financial results on October 8, 2026.
IDT Corporation reported non-GAAP EPS of $0.94 for the fourth quarter of 2026, missing analyst estimates by $0.04. According to a company statement via GlobeNewswire reported by Reuters, revenue reached $339 million, beating expectations by $20 million, even as gross profit grew by 18% during the period.
Full-year income from operations reached $121 million, up 21%, while Adjusted EBITDA rose 17% to $155 million for the 2026 fiscal year. IDT closed at $67.46 on September 25, 2026, with the stock trading between a low of $67.27 and a high of $68.54 during that session.
AngioDynamics will release its fiscal 2027 first quarter financial results on October 8, 2026. ANGO closed at $15.49 on September 25, 2026.